INS and sarcopenia: Hence, the LCFA pentadecanoic acid accumulates in skeletal muscle, where it promotes the production of inflammatory mediators, insulin resistance, skeletal muscle protein consumption, and muscle fiber atrophy, and decreases skeletal muscle mass and content, which reflects the etiology and pathogenesis of sarcopenia.